Lipid-lowering interventions in managed care settings

The American Journal of Medicine
J Fox, K Jones

Abstract

Effective screening, treatment, and follow-up of patients with elevated serum lipid levels is important because of the very strong association between this condition and coronary heart disease (CHD). Screening of patients with and without CHD for hyperlipidemia is not generally carried out properly by managed care organizations (MCOs) or in other settings. Primary and secondary prevention are inadequate in most patients with this condition; even in patients who are treated, lipid-lowering therapy is often not used to its full potential. These trends have been confirmed by findings in the first of a three-phase hyperlipidemia outcomes management program carried out at 27 US MCOs. The efficacy of lipid-lowering therapy can be enhanced by physician education and comprehensive, integrated quality improvement programs. The cost-effectiveness of such treatment can be improved by individualizing both drug and dose to achieve National Cholesterol Education Program goals at the lowest drug acquisition cost. The quality improvement program described and others like it have the potential to reduce the morbidity and mortality associated with CHD while decreasing the huge economic burden associated with this disease. Several such programs h...Continue Reading

References

Jun 1, 1996·The American Journal of Medicine·J J Marcelino, K R Feingold
Oct 1, 1996·The Journal of Cardiovascular Nursing·N J Brass-Mynderse
Aug 1, 1997·Social Science & Medicine·A LylesA M Rentz
Aug 1, 1997·Social Science & Medicine·H Grabowski, C D Mullins
Oct 8, 1999·Lancet·N Payne, C McCabe
Jan 1, 2000·QJM : Monthly Journal of the Association of Physicians·D E FlanaganM Armitage
Jan 5, 2000·Academic Medicine : Journal of the Association of American Medical Colleges·L L CasebeerR E Kristofco
Jan 13, 2000·Journal of General Internal Medicine·S R MajumdarS B Soumerai
Feb 23, 2000·Journal of Cardiovascular Pharmacology and Therapeutics·M KhanJ Duff
Mar 24, 2000·Journal of the American Pharmaceutical Association : APhA·K M NolaB Regel
Apr 20, 2001·The American Journal of Medicine·B Patel, H E Perez
Apr 20, 2001·The American Journal of Medicine·L M Latts

❮ Previous
Next ❯

Citations

Sep 30, 2008·American Journal of Medical Quality : the Official Journal of the American College of Medical Quality·James M Gill, Yingxia Chen
Oct 24, 2009·Population Health Management·James M GillMichael I Lieberman
May 3, 2007·Blood Pressure·S SkrticUNKNOWN RIAHD Study Group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
Michael SchatzVirginia P Quinn
Journal of the American Medical Women's Association
D L Moore, S Bernard
© 2021 Meta ULC. All rights reserved